NCT07002372Recruiting
Effect of Video Viewing on Intravitreal Injection Experience
Impact of Procedural Video Viewing on Patients Undergoing Intravitreal Anti-VEGF Injections
Source: ClinicalTrials.gov · Last updated 3 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Study Objective The goal of this clinical trial is to evaluate whether viewing a procedural video can improve the patient experience and reduce the incidence and severity of subconjunctival hemorrhage in individuals undergoing intravitreal anti-VEGF injections. Key Research Questions 1. Can viewing the procedural video prior to treatment reduce the rate and/or area of subconjunctival hemorrhage? 2. Can the video improve the patient experience, specifically by reducing anxiety levels and increasing satisfaction with the treatment process? Study Design Participants will be randomly assigned to either an intervention group, who will watch an educational video explaining the injection procedure, or a control group, who will not view the video. All participants will complete the State-Trait Anxiety Inventory-State (STAI-S) questionnaire both before and after treatment to assess changes in anxiety levels.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 182 (estimated)
- First submitted
- 20 May 2025
- Start date
- 5 May 2025
- Primary completion date
- 5 Aug 2025
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Diseases
- Macular degeneration, Diabetic eye disease
- NCT number
- NCT07002372
What you commit to
- Study type: Interventional
- Planned participants: 182
- From 5 May 2025 to the primary completion date, 5 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of previous eye surgery
Other
- Best-corrected visual acuity in the better eye worse than 0.3
- The target eye is complicated with neovascular glaucoma.
Who the study is looking for
- Patients who are receiving their first intravitreal injection of anti-VEGF medication due to retinal diseases
- Mentally competent, and able to communicate without barriers
- Willing to voluntarily sign an informed consent form.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Second Affiliated Hospital, School of Medicine, Zhejiang University Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.